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Abstract
Background: Osteoporosis and associated fractures are a major public health burden and there is great need for a
large animal model. Melatonin, the hormone of the pineal gland, has been shown to influence bone metabolism.
This study aims to evaluate whether absence of melatonin due to pinealectomy affects the bone mass, structure
and remodeling in an ovine animal model.
Methods: Female sheep were arranged into four groups: Control, surgically ovariectomized (Ovx), surgically
pinealectomized (Px) and Ovx+Px. Before and 6 months after surgery, iliac crest biopsies were harvested and
structural parameters were measured using μCT. Markers of bone formation and resorption were determined. To
evaluate long term changes after pinealectomy, bone mineral density (BMD) was analyzed at the distal radius at 0,
3, 9, 18 and 30 months.
Results: Cancellous bone volume (BV/TV) declined after 6 months by -13.3% Px and -21.5% OvxPx. The bone loss
was due to increased trabecular separation as well as decreased thickness. The histomorphometric quantification
and determination of collagen degradation products showed increased bone resorption following pinealectomy.
Ovariectomy alone results in a transient bone loss at the distal radius followed by continuous increase to baseline
levels. The bone resorption activity after pinealectomy causes a bone loss which was not transient, since a
continuous decrease in BMD was observed until 30 months.
Conclusions: The changes after pinealectomy in sheep are indicative of bone loss. Overall, these findings suggest
that the pineal gland may influence bone metabolism and that pinealectomy can be used to induce bone loss in
sheep.
Background
Treatment of osteoporotic fractures remains generally
an unsolved problem[1]. The application of conventional
implants for fracture fixation in osteoporotic bone is
limited mostly because of the weakened bone structure
[2]. Prior to the implementation of new treatment
options into the clinical situation, in-vivo testing of new
treatments or devices is required to prove efficiency and
safety. Hence, an animal model is indispensable for
demonstrating the benefit of any new modality suffi-
ciently different from the standard treatment. The FDA
Guideline recommend that agents should be evaluated
in two different animal species including ovariectomized
rats and a second non-rodent large animal model which
possesses Haversian systems and remodelling patterns
similar to the human situation[3]. Therefore a large ani-
mal model of osteoporosis is required[4].
Contrary to humans, naturally occurring osteoporosis
is hardly found in animals, and osteoporosis can only be
induced in them. The ovariectomized rat is the animal
model studied most for osteoporosis. But, biomechanical
implant testing is limited and cortical bone remodelling
is different than in humans[5,6]. A comparison of the
other common experimental animals to potentially
simulate human osteoporosis shows that the sheep ful-
fils many of the qualifications[7]. Ovariectomy (Ovx)
alone has been demonstrated to induce a significant
decrease of bone mass density in sheep[8,9] but the
changes in the bone mass have been observed directly
after Ovx only and no long-term effect was found [10].
The bone loss is much lower in comparison to human
osteoporosis and would be better termed osteopenia[4].* Correspondence: marcus.egermann@med.uni-heidelberg.de
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Melatonin is the principal substance secreted by the
pineal gland with roles of biologic regulation of circa-
dian rhythms, aging and reproduction. There is consid-
erable interest in the potential role of melatonin in bone
metabolism[11]. The finding that bone marrow cells of
mice are capable of synthesizing melatonin suggest that
this hormone may have local regulatory actions in bone
[12]. Consistent with the possibility of direct bone
actions, melatonin stimulates cell proliferation and activ-
ity on osteoblasts[13] and enhances human adult
mesenchymal stem cell differentiation into osteoblasts
[14]. Daily injections of 50 mg/kg/day of melatonin sig-
nificantly increased bone mineral density and trabecular
structure in mice[15]. These skeletal effects probably
were caused by the melatonin-mediated down-regulation
of the RANKL-mediated osteoclast formation and acti-
vation. Furthermore, melatonin is suspected to be
involved in the age-related disorder of osteoporosis[16].
Accordingly, the secretion of melatonin declines pro-
gressively with increasing age. The menopause is time-
related with a substantial decrease in melatonin secre-
tion and an associated increase in the rate of pineal cal-
cification[17,18]. A recent report also shows that obese
women (who have a low risk for osteoporosis) have a
higher daytime secretion of melatonin compared with
non-obese women and that the melatonin level in the
obese women is associated with a reduction in serum
bone turnover markers[19]. Ladizesky et al concluded
from their results that melatonin modifies bone remo-
deling after ovariectomy and the effect may need ade-
quate concentrations of estradiol[20,21]. Pinealectomy
reduces the nocturnal expression of melatonin and
causes an increase of collagen degradation products in
rats[22]. Thus, there is circumstantial evidence that mel-
atonin may alter bone metabolism.
The rationale of this study is to establish a large ani-
mal model of osteoporosis by decreasing the endogen-
ous levels of melatonin using pinealectomy. Our
approach is to investigate the short and long term effect
of Px compared to Ovx and OvxPx on the bone mineral
density, bone structure and bone metabolism in sheep.
Methods
Study design
The European laws on animal experimentation were
observed strictly during the entire study and the animal
research protocol was approved by the appropriate insti-
tutional animal care committee (Veterinary Department
of the Canton of Grisons). Mature and identically bred
female White Swiss Alpine Sheep (3.1 ± 0.5 yrs, weight:
67.7 ± 2.7 kg) were arranged into four groups: untreated
control (C; n = 8), ovariectomy (Ovx; n = 6), pinealect-
omy (Px n = 6) and ovariectomy in combination with
pinealectomy (OvxPx; n = 6). Before and 6 months after
surgery, bicortical iliac crest biopsies were harvested to
determine structural parameters using μCT and histo-
morphometry. Urine and serum samples were collected
three times (day 28, 14 and 7) before surgery as baseline
level and at 3, 6 and 9 months to analyze biochemical
markers of bone metabolism. In order to additionally
examine the long term effect of pinealectomy on bone
mass, bone mineral density (BMD) was measured before
and 3, 9, 18 and 30 months after surgery at the distal
radius using peripheral quantitative computed tomogra-
phy (pQCT). The full number of animals were available
for all assays mentioned.
The sheep were held in large group boxes under stan-
dardized conditions and natural light, and were given
access to pasture land during the day. The animals were
fed twice daily with silage, hay and straw as well as
water ad libidum. Their body weight was measured
biweekly.
Surgical procedures
All surgical procedures were performed under general
anaesthesia with Isoflurane and intravenous Buprenor-
phine 0.3 mg/ml. For bilateral ovariectomy the ewes
were placed in supine position, midventral laparotomy
was performed, with care being taken to ligate doubly
the ovarian ligament, artery and vein.
For pinealectomy a parieto-occipital approach was
used as described[23,24] with the skull fixed into a
stereotactic frame (Davis Kopf Instruments Inc.,
Tujunga, USA). A triangular craniotomy was performed,
the dura mater was cut by scissor and reflected back.
The left occipital lobe was carefully pushed laterally
revealing the falx cerebri and its caudal extension the
tentorium cerebelli. The great vein of Galen runs ante-
rior to the pineal gland and acts as a guiding structure.
The collicular plate was fully exposed, the pineal gland
recognized by the characteristic color and shape (Figure
1C) and finally completely removed. Hemorrhage was
meticulously controlled.
Bicortical transiliacal biopsies were taken in prone
position using a trephine drill (internal diameter 6.4
mm) at 1 cm below the iliac crest. The first biopsy was
randomly distributed to the right and left pelvic bone
and the second biopsy was taken at the contralateral
side.
Structural parameters in micro-CT
After harvesting transiliacal biopsies and immediate fixa-
tion in 70% Ethanol the trabecular micro-structure was
evaluated using a μCT imaging system. The microtomo-
graphic imaging system (μCT 40, Scanco Medical, Bas-
sersdorf, Switzerland) was equipped with a 5 μm focal
spot X-ray tube as a source. The spatial resolution was
22 μm in all directions. The volume of interest included
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a cube with a side length of 4 mm and was binarized
using a uniform threshold of 300 (30% of the gray
scale). The scans were automatically reconstructed to a
3-D cube and analyzed by associated analysis software
for bone volume to tissue volume ratio (BV/TV), bone
surface to bone volume ratio (BS/BV), trabecular num-
ber (Tb.N), trabecular thickness (Tb.Th), trabecular
separation (Tb.Sp) and structural model index (SMI)
[25].
Histomorphometry
The biopsies were dehydrated, embedded in Polymethyl-
metacrylate (PMMA) and sections of 6 μm were cut in
the sagital plane, then stained with Giemsa-eosin. Two
pairs of slices of each biopsy with a distance >1000 μm
between the pairs, were processed for histomorphome-
try. Pictures were obtained with a light optical micro-
scope (Axioplan 2 imaging, Carl Zeiss, Germany) and a
digital camera (Axiocam, Carl Zeiss, Germany). The sta-
tic derived bone histological parameters according to
the guidelines outlined by the ASBMR [26] were calcu-
lated by histomorphometric software (KS400, Version
3.0, Carl Zeiss, Germany). The outcome variables
included: cortical width (Ct.Wi), bone area to total area
ratio (B.Ar/T.Ar), osteoid area to bone area ratio (O.Ar/
B.Ar), Osteoid perimeter to bone perimeter ratio (O.
Pm/B.Pm), eroded perimeter to bone perimeter ratio (E.
Pm/B.Pm), and osteoclast perimeter to bone perimeter
ratio (Oc.Pm/B.Pm).
Bone markers
Serum samples were stored at -20°C until assay. Serum
bone specific alkaline phosphatase (bALP) levels were
determined by ELISA, using the METRA BAP EIA kit
(TECOmedical AG, Suhr, Switzerland). Control samples
were within the range indicated by the manufacturer:
Figure 1 Melatonin levels, pineal gland and body weight. The day profiles of serum melatonin levels (mean values) before (A) and after (B)
surgery demonstrate the absence of nocturnal melatonin expression after pinealectomy. Anatomy of the ovine brain (C): The pineal gland
(arrow) is located on the collicular plate of the brainstem and recognized by the characteristic color and shape (C). The course of the mean
body weight (D) shows lower values in the post-operative period for the Px and OvxPx group compared to control (*: p < 0.05 at some time
points).
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14.9 and 15.4 U/L for low control (range 9.8 - 21.1 U/
L); 64.3 and 86.6 U/L for high control (range 62.0 - 97.2
U/L).
Deoxypyridinoline (DPD) crosslinks in sheep urine
were measured as recently described using the METRA
DPD ELISA (TECOmedical AG, Suhr, Switzerland). The
DPD results were corrected for urinary concentration by
creatinine[10].
For a quantitative measure of the excretion of pyridi-
noline (PYD) crosslinks in serum, the METRA Serum
PYD EIA kit (TECOmedical AG, Suhr, Switzerland) was
used. Control samples were measured as 2.0 and 2.3
nmol/L for low control (range 1.6. - 2.6 nmol/L) and 6.5
and 8.1 nmol/L for high control (range: 6.3 - 10.4 nmol/
L).
Melatonin was measured at the Center for Experimen-
tal Pathology in Locarno by radioimmunoassay (RIA),
using 125I-melatonin (DDV Diagnostica, Marburg, Ger-
many). The sensitivity of the method was of 2 pg/ml
and the interassay variability less than 15%.
BMD-measurement
The bone mineral density (BMD in g/cm3) was mea-
sured by pQCT using a Densiscan 1000 (SCANCO
Medical AG, Bassersdorf, Switzerland). The distal radius
of both sides was examined under general anaesthesia to
avoid artifacts caused by movement. After fixation of
the limb in the CT scanner, the joint surface was
defined on a projectional scout view as reference line
and 10 consecutives slices were obtained going proxi-
mal. The effective energy of the X-ray beam was set to
40 keV and 0.5 mA. The slice thickness was 1 mm and
the spatial resolution was 290 × 290 μm. A contour sur-
rounding the radius on each cross section was detected.
The cancellous bone was measured using the interior
50% of a section (μ50-CT value) and the values from
both sides averaged for each animal.
Statistical analysis
Statistical analysis was performed using SPSS software
package (SPSS Inc., Chicago, USA). The normal distri-
bution of data was not given as tested by the Shapiro
Wilk test. Main effects of time within each group were
tested by non-parametric analysis of variance (Fried-
man). Differences between treatment groups (Ovx, Px,
OvxPx) and controls at each time point were analyzed
by non-parametric testing (Mann-Whitney U test). The
level of statistical significance was set at P < 0.05. Data
are given in mean ± standard deviation unless otherwise
stated.
Results
All animals tolerated the surgical procedures well with-
out any side effects. One ovariectomized sheep died at
16 months of observation due to oesophageal infection
which was not related to the treatment methods of this
study. The pinealectomy did not interfere with the gen-
eral health of the animals. Specifically, the circadian
rhythm observed by the animal care takers was in syn-
chrony with normal ewe in the same group. Complete
pinealectomy was confirmed by absence of nocturnal
melatonin secretion (Figure 1A+B). During the entire
observation period, the mean body weight fluctuated
over time (Figure 1D). A lower body weight in pinealec-
tomized animals was observed during the initial post-
operative phase. At several time points between 2 and 6
months after surgery the differences between Px and
OvxPx versus control group reached the level of
significance.
To characterize the changes in trabecular bone struc-
ture caused by pinealectomy and ovariectomy, we per-
formed static morphometry using three dimensional
micro-CT analysis of iliac crest bone biopsies (Figure 2).
At the beginning of the study there were no significant
differences between iliac crest biopsies of the four
groups. In all pinealectomized animals (Px, OvxPx) the
bone volume and trabecular number decreased after six
months by -13.3% (p = 0.013) and -7.6% (p = 0.010)
respectively. The trabecular separation (Tb.Sp) increased
by 12.2% (p = 0.009). Some changes in the trabecular
structure (Tb.N, Tb.SP) seems to be more pronounced
in the OvxPx-group compared to the Px-group (Figure
2). To further characterize the bone loss caused by pine-
alectomy full static histomorphometry for structural
parameters was performed on iliac crest biopsies(Table
1). Consistent with the data from μCT-analysis the bone
area declined in all treated groups (Ovx, Px and OvxPx)
(Figure 3). Ovariectomy led to a reduction in cortical
thickness that was observed in the Ovx and OvxPx
groups. No changes were observed on osteoid, indicating
that bone formation was not disturbed. In contrast,
osteoclast surface was increased in all groups treated by
pinealectomy, indicating stimulation of bone resorption.
The increase in eroded surface reached the level of sig-
nificance in OvxPx-group.
The serum levels of bone alkaline phosphatase was
significantly increased at 3 months after ovariectomy,
but not after pinealectomy (Figure 4A). Next bone
resorption markers by collagen degradation products
were measured as serum pyridinoline levels and urinary
deoxypyridinoline with transient increase after pinealect-
omy (Figure 4B+C).
Bone mineral density was examined at the distal
radius using pQCT. In order to exclude transient
changes after removal of the pineal gland, the animals
were followed up to 30 months and BMD was deter-
mined (Figure 5). Following surgery at the beginning of
the study a tendency of decline in the cancellous bone
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Figure 2 Micro-CT-Analysis. Morphometric analysis of trabecular bone using micro-CT scanning and 3D-reconstruction. Biopsies were taken
from the iliac crest before (0 months) and after (6 months) surgery. A: bone volume (BV/TV), B: bone surface (BS/BV), C: trabecular number (Tb.
N), D: trabecular thickness (Tb.Th), E: trabecular separation (Tb.Sp), F: structural model index (SMI). Boxplots show the median, interquartile range
and outliers (circle) of the variables. Differences between time points: * p < 0.05, ** p < 0.01. Differences between groups compared to control: ‡
p < 0.05, ‡‡ p < 0.01.
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Table 1 Bone Histomorphometry
control Ovx
0 months 6 months p 0 month 6 months p
Ct.Wi (μm) 858 ± 225 769 ± 358 0,249 717 ± 244 547 ± 154 0,007
B.Ar/T.Ar (%) 22,6 ± 4,3 21,7 ± 2,7 0,345 20,9 ± 5,0 18,0 ± 1,8 0,014
O.Ar/B.Ar (%) 0,225 ± 0,236 0,209 ± 0,153 0,764 0,072 ± 0,101 0,104 ± 0,116 0,314
O.Pm/B.Pm (%) 1,069 ± 1,092 0,920 ± 0,705 0,643 0,328 ± 0,481 0,504 ± 0,597 0,272
E.Pm/B.Pm (%) 1,952 ± 1,170 1,642 ± 1,036 0,293 1,625 ± 0,867 1,431 ± 0,757 0,419
Oc.Pm/B.Pm (%) 0,033 ± 0,043 0,039 ± 0,062 0,663 0,014 ± 0,033 0,027 ± 0,046 0,289
Px OvxPx
0 months 6 months p 0 month 6 months p
Ct.Wi (μm) 582 ± 127 637 ± 278 0,341 686 ± 125 552 ± 118 0,000
B.Ar/T.Ar (%) 19,3 ± 3,7 16,8 ± 3,7 0,015 19,7 ± 3,6 17,2 ± 2,857 0,011
O.Ar/B.Ar (%) 0,332 ± 0,323 0,327 ± 0,228 0,946 0,292 ± 0,626 0,303 ± 0,265 0,936
O.Pm/B.Pm (%) 1,545 ± 1,371 1,461 ± 1,029 0,800 1,249 ± 1,687 1,328 ± 1,065 0,846
E.Pm/B.Pm (%) 1,634 ± 1,135 1,920 ± 0,951 0,316 1,322 ± 0,862 2,230 ± 1,446 0,011
Oc.Pm/B.Pm (%) 0,012 ± 0,020 0,052 ± 0,078 0,011 0,021 ± 0,042 0,062 ± 0,068 0,017
Bone histomorphometry of biopsies from iliac crest. Six months after surgery bone area is decreased in all treated groups. Px and OvxPx increases the bone
resorption indices including eroded perimeter and osteoclast perimeter indicating stimulated bone resorption.
Figure 3 Bone Histomorphometry. Trabecular bone loss can be
observed in all treated groups on representative slides of the iliac
crest biopsies at three month after surgery. (Ovx = Ovariectomy, Px
= Pinealectomy, OvxPx = Ovariectomy + Pinealectomy).
Figure 4 Biochemical Marker . Biochemical markers of bone
metabolism are presented as changes relative to baseline levels. A:
serum levels of bone specific alkaline phosphatase (bALP). B: Serum
levels of pyridinoline (PYD). C: Urine levels of deoxypyridinoline
(DPD). Differences within the group compared to base line: * p <
0.05.
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mineral density (BMD) was observed in all groups. At
later time points the BMD in control sheep slightly
increased but overall remained constant at baseline
levels of ~ 0.7 g/cm3. In ovariectomized sheep the initial
cancellous bone loss of -12.7% at 3 months reached the
level of significance (p = 0.008) followed by a phase of
progressive increase in bone mass until 30 months post
surgery. Whereas the pinealectomized animals demon-
strated a continuous bone loss of -14.4% (Px, p = 0.009
between 0 and 30 months) and -14.7% (OvxPx, p =
0.001 between 0 and 30 months) until the end of the
observation period (Figure 5).
Discussion
The clinical aspects of osteoporosis are of great interest
to orthopaedic surgeons, as many problems in the treat-
ment of osteoporosis-associated fractures seem to be
related to the reduction in bone mass. There is great
need of a suitable animal model for experimental studies
on fracture healing and fracture treatment in osteoporo-
tic bone, as well as of a better understanding of the
pathogenesis of this affliction[4].
Osteoporosis needs to be induced in animals. Ovar-
iectomy simulates the post-menopausal estrogen deple-
tion and a mild bone loss was observed after Ovx in
sheep[8,9]. Consistent with the literature, in the present
study ovariectomy leads to an initial bone loss of 12%.
Interestingly, this bone loss seems to be transient and a
rebound was observed after 6 months. Further studies
are needed to explain this phenomenon, which may be
related to the production of estrogen by alternative
tissues. However, this mild reduction of BMD does not
match the WHO criteria for osteoporosis in humans
with a decrease of BMD by -2.5 SD.
Although there is evidence that estrogen deficiency is
an important contributory factor, the pathogenesis of
post-menopausal osteoporosis is multifactorial. Clinical
studies suggest that characteristic changes of bone mass
in postmenopausal osteoporosis, resulting from predo-
minance of resorptive process over those leading to
bone tissue formation, may be related to melatonin[16].
A few studies, particularly experimental, suggest that the
main neuro-hormone of pineal gland, melatonin, can
influence bone tissue metabolism[11]. Ostrowska et al
have been shown that pinealectomy in rat increases col-
lagen degradation marker as biochemical markers of
bone resorption. These changes were more pronounced
in ovariectomized rats[22]. Interestingly the surgical
pinealectomy in newly-hatched chicks has a significant
effect on the development of intervertebral disc degen-
eration[27].
In order to establish a large animal model for osteo-
porosis, we transferred the findings mentioned above to
an ovine model. Bone structural parameters were deter-
mined from iliac crest biopsies indicating a significant
bone loss after pinealectomy that could be attributed to
an increase in trabecular separation and decrease in tra-
becular thickness. Some of the changes on bone struc-
tural parameters after pinealectomy were more
pronounced in sheep that also underwent ovariectomy.
Similar findings were reported in rat, where pinealect-
omy had an inducing effect upon the level of
Figure 5 Bone Mineral Density. The long term course of trabecular bone mineral density at the distal radius. A rapid bone loss was observed
in the initial phase after surgery with highest bone loss in Ovx sheep. At later time points a continuous bone loss was found in all
pinealectomized animals in contrast to Ovx sheep, which showed a minimal increase in BMD. (*: p < 0.05, **: p < 0.01 compared to control
group)
Egermann et al. BMC Musculoskeletal Disorders 2011, 12:271
http://www.biomedcentral.com/1471-2474/12/271
Page 7 of 9
investigated markers of bone metabolism in combina-
tion with ovariectomy[22].
The changes in ovariectomized ewes observed in the
present work confirmed those in previous studies. Cha-
vassieux reported a transient increase in biochemical
markers 3 months after ovariectomy and changes in cor-
tical bone histomorphometric parameters without altera-
tions in cancellous bone[9]. In contrast we have shown
that pinealectomy in ewe decreases the cancellous bone
volume without affecting the cortical structures. A
synergistic effect seems to exist when Ovx and Px are
combined in the present study. The bone loss affects the
cancellous as well as cortical structures. Taken together,
these data show that pinealectomy in ewes results in an
increase in bone resorption as indicated by the histo-
morphometric and biochemical changes. These changes
result in osteopenia observed at the iliac crest and the
distal radius. These data show that Ovx and Px affects
bone metabolism resulting in bone loss, supporting the
assumption that the pathogenesis of post-menopausal
osteoporosis is multifactorial.
At first glance this pinealectomy model including the
neurosurgical approach might be a bit extreme for a
widely used animal model but it seems to simulate post-
menopausal osteoporosis. Leptin is known for the cen-
tral regulation of bone mass and we could recently
demonstrate, that the intra-cerebral injection of leptin
causes bone loss in sheep[28]. However, leptin acts
through the inhibition of bone formation and this is not
the major cause of bone loss in post-menopausal osteo-
porosis. Furthermore, and in contrast to recently pub-
lished sheep models for osteoporosis using leptin or
glucocorticoids[28-30], there is minimal concern on ani-
mal welfare[31] and animals do not require special care
after removal of the pineal gland.
Because this is a study with a limited number of ani-
mals, there are still several aspects of pinealectomy on
bone remodelling that are not specifically addressed in
the present work. These include the potential of melato-
nin application to reverse the effect of pinealectomy and
to inhibit the observed bone loss, as previously shown
in small animal models[15,20]. Furthermore, a signifi-
cant bone loss at the iliac crest was seen at 6 months
after Px and OvxPx. Although these results go along
with the suspected role of melatonin on bone metabo-
lism, the effect of pinealectomy on bone can not be dis-
tinguished from the surgical procedure only. The lack
of a sham operated group is the major criticism of this
study. We omitted the sham group to reduce the num-
ber of animals as required by the local ethical commit-
tee. However, in order to discriminate any effects due
to the neurosurgical procedure from the influence of
pinealectomy on bone, we decided to analyze the long
term effect of pinealectomy. One year after surgery the
effect seen on bone mass must be due to pinealectomy
only and additional effects of the procedure can be
excluded. Therefore bone mineral density was deter-
mined up to 2.5 years after surgery using the pQCT
method. Additional bone biopsies were not taken since
the healing of the former biopsy holes would have
altered the newly formed bone tissue, making the inter-
pretation of the results difficult. This long-term obser-
vation clearly shows that the influence of pinealectomy
on bone is not transient and, in contrast to ovariect-
omy, a continuous decrease in BMD was observed. Dur-
ing this study extension an increase of BMD at the
distal radius was observed in untreated controls. This
effect might be related to an increased access to the
paddock which is often associated with higher physical
activity.
Conclusions
In this experimental study pinealectomy in sheep
resulted in a reduction in BMD and bone structure
associated with increased bone resorption. Taken
together these data provide a direct evidence for the
existence of a pineal gland action on bone remodeling
beyond rodents. As a consequence of this study it seems
that melatonin deficiency may be a cofactor in inducing
bone mass changes. Melatonin is just one candidate for
hormonal modulation of osteoblast and osteoclast func-
tion and therefore this project contributes to a better
understanding of bone biology and bone remodeling.
Although a significant bone loss was observed in the
present study, an adequate bone loss according to the
definition of osteoporosis (-2.5 SD) could not be
achieved. Future studies are needed to combine the
numerous candidates that are able to modulate bone
metabolism like melatonin, leptin and estrogen in order
to obtain a synergistic effect with bone loss that simu-
lates the situation in human.
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